Michael Higgins's Stock Ratings

Ladenburg Thalmann Analyst

Michael Higgins is an analyst at Ladenburg Thalmann. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/06/2025

Overall Average Return

5.24%

Smart Score

47.8%

Overall Average Return Percentile

52nd

Number of Ratings

60
Buy NowGet Alert
08/14/2024MRNSBuy Now
Marinus Pharma
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
05/09/2024VRDNBuy Now
Viridian Therapeutics
$13.12
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
04/08/2024FBRXBuy Now
Forte Biosciences
$7.30-62.33%
Michael Higgins47%
→ $2.75UpgradeNeutral → BuyGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
Michael Higgins47%
$17 → $13MaintainsBuyGet Alert
05/02/2023OVIDBuy Now
Ovid Therapeutics
$0.312166.84%
Michael Higgins47%
→ $7Reiterates → BuyGet Alert
04/03/2023SCYXBuy Now
SCYNEXIS
$1.001403.76%
Michael Higgins47%
→ $15Reiterates → BuyGet Alert
04/03/2023ARTLBuy Now
Artelo Biosciences
$1.005900%
Michael Higgins47%
→ $60Reiterates → BuyGet Alert
03/09/2023VRDNBuy Now
Viridian Therapeutics
$13.12204.88%
Michael Higgins47%
→ $40Reiterates → BuyGet Alert
03/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$63.90-45.23%
Michael Higgins47%
→ $35Reiterates → BuyGet Alert
01/05/2023TRYPFBuy Now
Tryp Therapeutics
Michael Higgins47%
→ $1.5Reiterates → BuyGet Alert
09/09/2022PTNBuy Now
Palatin Techs
$0.1827646.95%
Michael Higgins47%
$2 → $50MaintainsBuyGet Alert
08/16/2022VRDNBuy Now
Viridian Therapeutics
$13.12204.88%
Michael Higgins47%
$33 → $40MaintainsBuyGet Alert
05/12/2022PHGEBuy Now
BiomX
$0.581279.31%
Michael Higgins47%
$13 → $8MaintainsBuyGet Alert
02/17/2022RYTMBuy Now
Rhythm Pharmaceuticals
$63.90-76.53%
Michael Higgins47%
→ $15UpgradeNeutral → BuyGet Alert
09/03/2021FBRXBuy Now
Forte Biosciences
$7.30
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
08/26/2021TRYPFBuy Now
Tryp Therapeutics
Michael Higgins47%
Initiates → BuyGet Alert
08/04/2021RYTMBuy Now
Rhythm Pharmaceuticals
$63.90
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
05/13/2021LBPSBuy Now
4d pharma
Michael Higgins47%
→ $35Initiates → BuyGet Alert
05/12/2021CATBBuy Now
Catabasis Pharmaceuticals
Michael Higgins47%
→ $6Initiates → BuyGet Alert
04/15/2021PHGEBuy Now
BiomX
$0.584210.34%
Michael Higgins47%
→ $25Initiates → BuyGet Alert
02/12/2021ARTLBuy Now
Artelo Biosciences
$1.00600%
Michael Higgins47%
→ $7Initiates → BuyGet Alert
01/25/2021VRDNBuy Now
Viridian Therapeutics
$13.12
Michael Higgins47%
Initiates → BuyGet Alert
08/05/2020NVAXBuy Now
Novavax
$6.271574.64%
Michael Higgins47%
→ $105DowngradeNeutral → SellGet Alert
07/08/2020NVAXBuy Now
Novavax
$6.271574.64%
Michael Higgins47%
$50 → $105DowngradeBuy → NeutralGet Alert
06/22/2020FBRXBuy Now
Forte Biosciences
$7.30
Michael Higgins47%
Initiates → BuyGet Alert
02/07/2020ZGNXBuy Now
Zogenix
Michael Higgins47%
$60 → $35DowngradeBuy → NeutralGet Alert
01/04/2019VIRTBuy Now
Virtu Finl
$41.95-30.87%
Michael Higgins47%
→ $29UpgradeNeutral → BuyGet Alert
10/19/2017EIGRBuy Now
Eiger BioPharmaceuticals
Michael Higgins47%
→ $35Initiates → BuyGet Alert
09/27/2017SVRABuy Now
Savara
$3.34
Michael Higgins47%
Reinstates → BuyGet Alert
08/10/2017VIRTBuy Now
Virtu Finl
$41.95-61.86%
Michael Higgins47%
→ $16Reinstates → NeutralGet Alert
08/10/2017CEMPBuy Now
Cempra
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
02/27/2017CEMPBuy Now
Cempra
Michael Higgins47%
UpgradeNeutral → BuyGet Alert
02/09/2017ADHDBuy Now
Alcobra Ltd. - Ordinary Shares
Michael Higgins47%
UpgradeNeutral → BuyGet Alert
12/13/2016ROKABuy Now
Roka Bioscience
Michael Higgins47%
→ $10Initiates → BuyGet Alert
12/01/2016ITEKBuy Now
Inotek Pharmaceuticals
Michael Higgins47%
Initiates → BuyGet Alert
11/16/2016GUIDBuy Now
Guidance Software, Inc. - Common Stock
Michael Higgins47%
Initiates → BuyGet Alert
09/15/2016APICBuy Now
Apigee
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
09/01/2016INVNBuy Now
InvenSense
$18.03-50.08%
Michael Higgins47%
→ $9Initiates → BuyGet Alert
09/01/2016QLIKBuy Now
QLIK TECHNOLOGIES INC COM
Michael Higgins47%
→ $1.5Assumes → BuyGet Alert
07/28/2016SYRGBuy Now
Synergy Resources
Michael Higgins47%
UpgradeNeutral → BuyGet Alert
07/25/2016OUTRBuy Now
Space Acquisition Corp. I
Michael Higgins47%
DowngradeNeutral → SellGet Alert
06/29/2016DMDBuy Now
Demand Media
Michael Higgins47%
Initiates → BuyGet Alert
06/21/2016ADHDBuy Now
Alcobra
Michael Higgins47%
Assumes → BuyGet Alert
06/09/2016ETRMBuy Now
EnteroMedics
Michael Higgins47%
$3 → $0.5DowngradeBuy → NeutralGet Alert
06/07/2016CEMPBuy Now
Cempra
Michael Higgins47%
Assumes → BuyGet Alert
06/03/2016TSLBuy Now
Trina Solar
$10.71-25.3%
Michael Higgins47%
$12 → $8DowngradeBuy → NeutralGet Alert
05/31/2016CPXXBuy Now
Celator Pharmaceuticals
Michael Higgins47%
$26 → $30.25DowngradeBuy → NeutralGet Alert
05/26/2016APICBuy Now
Apigee
Michael Higgins47%
$15 → $17MaintainsBuyGet Alert
05/09/2016KKDBuy Now
Krispy Kreme Doughnuts
Michael Higgins47%
$24 → $21DowngradeBuy → NeutralGet Alert
05/05/2016SYRGBuy Now
Synergy Resources
Michael Higgins47%
$9.5 → $6.25MaintainsNeutralGet Alert
04/12/2016BITIBuy Now
Biotie Therapies
Michael Higgins47%
Terminates Coverage OnGet Alert
03/22/2016MVGBuy Now
MAG Silver
Michael Higgins47%
$9 → $10.5MaintainsBuyGet Alert
03/21/2016BDEBuy Now
Black Diamond
Michael Higgins47%
$4 → $5MaintainsNeutralGet Alert
03/21/2016SNAKBuy Now
Inventure Foods
Michael Higgins47%
$12 → $8MaintainsBuyGet Alert
03/15/2016CPXXBuy Now
Celator Pharmaceuticals
Michael Higgins47%
$18 → $22MaintainsBuyGet Alert
03/15/2016OUTRBuy Now
Space Acquisition Corp. I
Michael Higgins47%
$23.5 → $35UpgradeSell → NeutralGet Alert
03/11/2016GALEBuy Now
Galena Biopharma
Michael Higgins47%
$6 → $5MaintainsBuyGet Alert
02/26/2016PPHMBuy Now
Peregrine Pharmaceuticals
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
02/26/2016PPHMBuy Now
Peregrine Pharmaceuticals
Michael Higgins47%
DowngradeBuy → NeutralGet Alert
02/25/2016ACPWBuy Now
Active Power
Michael Higgins47%
→ $1DowngradeBuy → NeutralGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free